1. Home
  2. Pulmonary hypertension
  Subject:

Pulmonary hypertension   New Search

View on DBpedia    View on Wikipedia
Top related subjects:
 Pulmonary artery Echocardiography Ventricular system Hypertension Hemodynamics Disease Vasoconstriction Tumor hypoxia Sildenafil Protein Pulmonary hypertension CT scan Medical ultrasound Ejection fraction Mitral valve Atrial septal defect Magnetic resonance imaging Obesity Diabetes mellitus Syndrome Logistic regression Diabetes mellitus type 2 Coronary circulation Cardiac output Aorta Shear stress Chemotherapy PubMed Vasodilation Enzyme inhibitor Endothelium Vasoactivity Apoptosis Metastasis Angiogenesis Messenger RNA Placebo TimesDaily Tadalafil Gene Western blot Acid
RELATED SUBJECTS:
The publications listed also have these subjects
Pulmonary artery  15 times
Echocardiography  10 times
Ventricular system  5 times
Sildenafil  5 times
Protein  5 times
Hemodynamics  5 times
Vasoconstriction  4 times
Tumor hypoxia  4 times
Placebo  4 times
Mouse  4 times
Hypertension  4 times
Heart  4 times
Gene  4 times
Ejection fraction  4 times
Apoptosis  4 times
Aortic valve  4 times
Aortic stenosis  4 times
Shortness of breath  3 times
Phosphorylation  3 times
Nitric oxide  3 times
Natriuretic peptide  3 times
Messenger RNA  3 times
Mechanistic target of rapamycin  3 times
Lung transplantation  3 times
Idiopathy  3 times
Growth factor  3 times
Flow cytometry  3 times
Disease  3 times
Catheter  3 times
Cardiac output  3 times
CT scan  3 times
Blood plasma  3 times
Atrial fibrillation  3 times
Aortic valve replacement  3 times
Western blot  2 times
Ventricular hypertrophy  2 times
Vasodilation  2 times
TimesDaily  2 times
Syndrome  2 times
Stromal cell-derived factor 1  2 times
Pulmonary alveolus  2 times
Protein kinase B  2 times
Phenotype  2 times
Multivariate analysis  2 times
Mitral valve  2 times
Mitogen-activated protein kinase  2 times
Metabolism  2 times
Medical ultrasound  2 times
Infarction  2 times
Immunohistochemistry  2 times
Hypoxemia  2 times
Hypertrophic cardiomyopathy  2 times
Hyperplasia  2 times
Histology  2 times
Fluoroscopy  2 times
Flow velocity  2 times
Fibrosis  2 times
Chronic obstructive pulmonary disease  2 times
Carbon monoxide  2 times
C-reactive protein  2 times
Bone marrow  2 times
Body mass index  2 times
Blood  2 times
Atrial septal defect  2 times
Afterload  2 times
World Health Organization  1 time
White blood cell  1 time
Von Willebrand factor  1 time
Vitamin B12  1 time
Ventricular septal defect  1 time
Ventricular remodeling  1 time
Univariate analysis  1 time
Tumor suppressor gene  1 time
Tumor necrosis factor alpha  1 time
Trypsin  1 time
Trimethoxyamphetamine  1 time
Tricuspid valve  1 time
Tremor  1 time
Transmission electron microscopy  1 time
Thymidine  1 time
Thylakoid  1 time
Thrombus  1 time
Thrombotic microangiopathy  1 time
Thrombosis  1 time
Thrombin  1 time
The Animals  1 time
Targeted therapy  1 time
Systemic scleroderma  1 time
Superoxide dismutase  1 time
Subcutaneous tissue  1 time
Stroke volume  1 time
Streptozotocin  1 time
Strain rate  1 time
Stent  1 time
Stenosis  1 time
Stem cell  1 time
Speckle tracking echocardiography  1 time
Spasticity  1 time
Small interfering RNA  1 time
Sleep apnea  1 time
Sirolimus  1 time
Sinus rhythm  1 time
Single Center  1 time
Serotonin  1 time
Seroma  1 time
Serine  1 time
Serbia  1 time
Selenium  1 time
Saccharomyces cerevisiae  1 time
STAT3  1 time
Route of administration  1 time
Rodent  1 time
Rheumatoid factor  1 time
Rheumatoid arthritis  1 time
Reuptake  1 time
Retinopathy  1 time
Reactive oxygen species  1 time
Pulmonary edema  1 time
Protein kinase  1 time
Prostaglandin-endoperoxide synthase 2  1 time
Polysomnography  1 time
Pneumothorax  1 time
Pleural effusion  1 time
Plasmid  1 time
Phosphodiesterase  1 time
Phosphatidylinositol  1 time
Peripheral neuropathy  1 time
Percutaneous aortic valve replacement  1 time
Paracrine signalling  1 time
P53  1 time
P38 mitogen-activated protein kinases  1 time
Oxidative stress  1 time
Odds ratio  1 time
Obstructive sleep apnea  1 time
Obesity  1 time
Nystagmus  1 time
Nuclear magnetic resonance  1 time
Non-small-cell lung carcinoma  1 time
Nitric oxide synthase  1 time
Nigeria  1 time
Neutrophil  1 time
Necrosis  1 time
Nature reserve  1 time
Natural reservoir  1 time
N-terminal prohormone of brain natriuretic peptide  1 time
Myosin  1 time
Myocarditis  1 time
Morphogenesis  1 time
Microtubule  1 time
Metastasis  1 time
Mechanical ventilation  1 time
Matrix metalloproteinase  1 time
Magnetic resonance imaging  1 time
Lymphocyte  1 time
Los Angeles  1 time
Logistic regression  1 time
Lipid peroxidation  1 time
Left ventricular hypertrophy  1 time
Lactose  1 time
Kinase  1 time
Italy  1 time
Ion  1 time
Intrauterine growth restriction  1 time
Intraperitoneal injection  1 time
Interquartile range  1 time
International  1 time
Interleukin 6  1 time
Inositol  1 time
Hypoxic hypoxia  1 time
Hypovolemia  1 time
Hypertrophy  1 time
Hyperoxia  1 time
Hydrolysis  1 time
Hydrogen bond  1 time
Hungary  1 time
House mouse  1 time
Hormone  1 time
Hepatocyte  1 time
Heparin  1 time
Heart valve repair  1 time
Heart valve  1 time
Heart failure  1 time
Hearing loss  1 time
Hazard ratio  1 time
Grafting  1 time
Glutathione peroxidase  1 time
Glucose  1 time
Genetic engineering  1 time
Gene therapy  1 time
Force-feeding  1 time
Flavonoid  1 time
Extracellular signal–regulated kinases  1 time
Exon  1 time
Erectile dysfunction  1 time
Epidemiology  1 time
Endothelium  1 time
Endocytosis  1 time
Emergency department  1 time
Embolism  1 time
Doppler echocardiography  1 time
Diabetic cardiomyopathy  1 time
Diabetes mellitus type 2  1 time
Diabetes mellitus  1 time
Descriptive statistics  1 time
Data warehouse  1 time
DNA  1 time
Cytoskeleton  1 time
Cyclic guanosine monophosphate  1 time
Cyclic adenosine monophosphate  1 time
Critical Role  1 time
Covariance  1 time
Coronary circulation  1 time
Coronary artery disease  1 time
Connective tissue disease  1 time
Confidence interval  1 time
Computer-aided design  1 time
Comparative genomic hybridization  1 time
Collagen  1 time
ClinicalTrials.gov  1 time
Circulatory system  1 time
Cholesterol  1 time
Chemokine receptor  1 time
Chemokine  1 time
Cell potency  1 time
Catalase  1 time
Cat  1 time
Caspase  1 time
Cardiomyopathy  1 time
Cardiac muscle  1 time
Capillary  1 time
Caffeine  1 time
CXCR4  1 time
CD133  1 time
C-Fos  1 time
Bronchopulmonary dysplasia  1 time
Brazil  1 time
Bone morphogenetic protein  1 time
Bleeding  1 time
Biopsy  1 time
Biomass  1 time
BT Group  1 time
Autosome  1 time
Autophagy  1 time
Ataxia  1 time
Asthma  1 time
Aspartate transaminase  1 time
Arterial blood gas  1 time
Aortic insufficiency  1 time
Antihypotensive agent  1 time
Angiography  1 time
Angiogenesis  1 time
Anesthesia  1 time
Anatomy  1 time
Alanine transaminase  1 time
Agranulocyte  1 time
Agonist  1 time
Adenoviridae  1 time
Adenosine  1 time
Acute respiratory distress syndrome  1 time
Actin  1 time
Acidosis  1 time
Acid  1 time
Acetylcholine  1 time

Publications tagged with this subject: 50

Note: Top 50 publications shown only. Open an item panel to view more info


1. Secoisolariciresinol diglucoside attenuates cardiac hypertrophy and oxidative stress in monocrotaline-induced right heart dysfunction

2. Very Small Embryonic-like Stem Cells Are Mobilized in Human Peripheral Blood during Hypoxemic COPD Exacerbations and Pulmonary Hypertension

3. Isolation, culture and identification of pulmonary arterial smooth muscle cells from rat distal pulmonary arteries

4. A pig model of acute right ventricular afterload increase by hypoxic pulmonary vasoconstriction

5. Prevalence and predictors of right ventricular diastolic dysfunction in peripartum cardiomyopathy

6. X-linked hypomyelination with spondylometaphyseal dysplasia (H-SMD) associated with mutations in AIFM1

7. Stress echo 2020: the international stress echo study in ischemic and non-ischemic heart disease

8. Invasive Hemodynamic Assessment of Patients with Heart Failure and Pulmonary Hypertension

9. Plasma Growth Differentiation Factor-15 is a Potential Biomarker for Pediatric Pulmonary Arterial Hypertension Associated with Congenital Heart Disease

10. Stromal derived factor-1 mediates the lung regenerative effects of mesenchymal stem cells in a rodent model of bronchopulmonary dysplasia

11. Intersectin-1s deficiency in pulmonary pathogenesis

12. Radiation-free CMR diagnostic heart catheterization in children

13. Sildenafil dosed concomitantly with bosentan for adult pulmonary arterial hypertension in a randomized controlled trial

14. Vasoproliferative process resembling pulmonary capillary hemangiomatosis in a cat

15. Pulmonary arterial hypertension in scleroderma: care gaps in screening

16. Contralateral Pulmonary Hypertension Following Resuscitation of Unilateral Ductal Origin of a Pulmonary Artery: A Multi-institutional Review

17. Riociguat in PAH and CTEPH: Strategies for Patient Management

18. Intravenous treprostinil infusion via a fully implantable pump for pulmonary arterial hypertension

19. Early characteristics of infants with pulmonary hypertension in a referral neonatal intensive care unit

20. Aquaporin 1 controls the functional phenotype of pulmonary smooth muscle cells in hypoxia-induced pulmonary hypertension

21. Altered mTOR and Beclin-1 mediated autophagic activation during right ventricular remodeling in monocrotaline-induced pulmonary hypertension

22. Relationship between matrix metalloproteinase-3 serum level and pulmonary artery systolic pressure in patients with rheumatoid arthritis

23. Combined methylmalonic acidemia and homocysteinemia presenting predominantly with late-onset diffuse lung disease: a case series of four patients

24. Idiopathic Pulmonary Arterial Hypertension in Children: A Review

25. BMP type II receptor as a therapeutic target in pulmonary arterial hypertension

26. Efficacy of 1, 5, and 20 mg oral sildenafil in the treatment of adults with pulmonary arterial hypertension: a randomized, double-blind study with open-label extension

27. Development and validation of a Score for Preoperative Prediction of Obstructive Sleep Apnea (SPOSA) and its perioperative outcomes

28. Use of the KlADH3 promoter for the quantitative production of the murine PDE5A isoforms in the yeast Kluyveromyces lactis

29. Pulmonary hypertension in lymphangioleiomyomatosis: prevalence, severity and the role of carbon monoxide diffusion capacity as a screening method

30. Left atrial dysfunction as a determinant of pulmonary hypertension in patients with severe aortic stenosis and preserved left ventricular ejection fraction

31. Exploratory analysis of the neutrophil to lymphocyte ratio in patients with pulmonary arterial hypertension

32. Exercise Testing and Stress Imaging in Mitral Valve Disease

33. Exercise Testing and Stress Imaging in Aortic Valve Disease

34. Argatroban Attenuates Diabetic Cardiomyopathy in Rats by Reducing Fibrosis, Inflammation, Apoptosis, and Protease-Activated Receptor Expression

35. The effective systematic heparin pre-treatment on thrombus formation on pulmonary artery catheter tips during pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension: a randomized, double-blind study

36. Value of CT signs and measurements as a predictor of pulmonary hypertension and mortality in symptomatic severe aortic valve stenosis

37. Severe persistent pulmonary hypertension of the newborn and dysmorphic features in neonate with a deletion involving TWIST1 and PHF14: a case report

38. Baicalin attenuates chronic hypoxia-induced pulmonary hypertension via adenosine A2A receptor-induced SDF-1/CXCR4/PI3K/AKT signaling

39. Physiological insights of recent clinical diagnostic and therapeutic technologies for cardiovascular diseases

40. Involvement of endothelial progenitor cells in the formation of plexiform lesions in broiler chickens: possible role of local immune/inflammatory response

41. Let-7a-transfected mesenchymal stem cells ameliorate monocrotaline-induced pulmonary hypertension by suppressing pulmonary artery smooth muscle cell growth through STAT3-BMPR2 signaling

42. Hemodynamic Evaluation of Children with Persistent or Recurrent Pulmonary Arterial Hypertension Following Complete Repair of Congenital Heart Disease

43. Pulmonary hypertension attenuates the dynamic preload indicators increase during experimental hypovolemia

44. CMR fluoroscopy right heart catheterization for cardiac output and pulmonary vascular resistance: results in 102 patients

45. Therapeutic Targeting of PDEs and PI3K in Heart Failure with Preserved Ejection Fraction (HFpEF)

46. Efficacy and safety of oral sildenafil in children with Down syndrome and pulmonary hypertension

47. Endothelial microparticles are increased in congenital heart diseases and contribute to endothelial dysfunction

48. Effect of pulmonary arteriovenous malformations on the mechanical properties of the lungs

49. Drug-induced pulmonary arterial hypertension: a review

50. Predictors of early restenosis after intracardiac echocardiography guided antegrade balloon aortic valvuloplasty in high-risk or inoperable patients


Questions?

Drop us a message.